Literature DB >> 3294304

Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF).

T S Kupper1, F Lee, D Coleman, J Chodakewitz, P Flood, M Horowitz.   

Abstract

Keratinocyte derived T-cell growth factor was initially described as a product of cultured neonatal keratinocytes and keratinocyte cell lines that induced the proliferation of HT-2 cells, a murine T-cell line that responds to IL-2 and IL-4 by incorporating 3H-Thymidine. Subsequently, KTGF has been purified to high specific activity and found to be distinct from IL-2 and IL-4 by a variety of biochemical, immunologic, and immunochemical criteria. Because it was found that certain HT-2 cell lines also proliferated in response to GM-CSF, the present study asked whether KTGF was related to GM-CSF. In this study, we demonstrate that antibodies to recombinant murine GM-CSF completely neutralize the capacity of KTGF to induce HT-2 proliferation without interfering with IL-2 or IL-4 induced HT-2 proliferation. Furthermore, poly-A+ RNA homologous to murine GM-CSF cDNA as judged by S1 nuclease analysis was detected in Pam 212 cells, and protein serologically homologous to GM-CSF was found in Pam 212 conditioned medium. We conclude that KTGF is identical to GM-CSF. The T-cell activating properties of GM-CSF require further exploration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294304     DOI: 10.1111/1523-1747.ep12464470

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X.

Authors:  A Tazi; M Bonay; A Bergeron; M Grandsaigne; A J Hance; P Soler
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

2.  Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes.

Authors:  M Cumberbatch; I Illingworth; I Kimber
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

Review 3.  Contact dermatitis. Clinical perspectives and basic mechanisms.

Authors:  A Nasir; A A Gaspari
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

4.  Increased contact hypersensitivity response in mice by topical application of 1 alpha,25-dihydroxyvitamin D3 to elicitation site.

Authors:  M Tani; Y Murata; S Harada; T Takashima; T Horikawa
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis.

Authors:  T S Kupper; F Lee; N Birchall; S Clark; S Dower
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

6.  Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

7.  Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor.

Authors:  N I Kim; K D Cooper; G J Fisher; O Baadsgaard; J J Voorhees; C Hammerberg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization.

Authors:  M Cumberbatch; S J Gould; S W Peters; I Kimber
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

9.  The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration.

Authors:  A M Moodycliffe; I Kimber; M Norval
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

10.  Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?

Authors:  G J Locker; I Simonitsch; R M Mader; E Warlamides; M F Gnant; R Jakesz; H Rainer; G G Steger
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.